CPRX Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for people with rare debilitating diseases.

$3.68  -0.29 (-7.20%)
As of 03/03/2021 15:59:54 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
11/08/2006
103,648,224
1,843,090
$410,446,967
0.00%
SEC Edgar Online
10-Q
10-K
14888U101
US14888U1016
B1G7Q03

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
5.74
2.62
3.47
45.63%
60.48%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy